AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

Managing type 1 diabetes has a substantial impact on quality of life and psychological health. Indeed, insulin overdosing can ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

It is widely accepted that sugar and foods high in sugar will make a child or young person hyperactive and extremely energetic. However, research conducted over the last 20 years has shown that sugar ...

Patients with knee osteoarthritis who received metformin demonstrated significant reductions in knee pain and increased ...

If you regularly experience headaches, add these foods to your diet to relieve the pain and uncomfortable symptoms.

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

What you eat could be the key to easing your headache or migraine symptoms. Though adjusting your diet is far from a miracle ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing ...

This study was designed "to detect differences between individualized homeopathic medicinal products (IHMPs) and placebo after 4 months of intervention in patients with chronic low-back pain (LBP)".